Insufficient scRNA-seq data for expression of CHRNB1 at single-cell level.
Insufficient scRNA-seq data for expression of CHRNB1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 656.36 | 2639 / 2642 | 100% | 15.60 | 704 / 705 |
thymus | 100% | 1112.16 | 653 / 653 | 99% | 21.62 | 601 / 605 |
breast | 100% | 470.69 | 457 / 459 | 95% | 7.52 | 1067 / 1118 |
kidney | 100% | 722.43 | 89 / 89 | 94% | 15.46 | 849 / 901 |
uterus | 100% | 434.32 | 170 / 170 | 94% | 11.15 | 430 / 459 |
pancreas | 100% | 823.41 | 328 / 328 | 92% | 7.22 | 164 / 178 |
liver | 100% | 793.88 | 226 / 226 | 87% | 6.39 | 353 / 406 |
bladder | 100% | 345.33 | 21 / 21 | 85% | 8.06 | 427 / 504 |
skin | 99% | 460.12 | 1796 / 1809 | 85% | 6.55 | 403 / 472 |
lung | 97% | 355.86 | 560 / 578 | 87% | 8.28 | 1007 / 1155 |
adrenal gland | 100% | 2535.71 | 258 / 258 | 79% | 8.64 | 181 / 230 |
ovary | 99% | 333.48 | 178 / 180 | 76% | 5.46 | 326 / 430 |
intestine | 100% | 409.63 | 964 / 966 | 70% | 5.35 | 367 / 527 |
esophagus | 99% | 436.85 | 1436 / 1445 | 62% | 4.39 | 114 / 183 |
prostate | 98% | 380.94 | 241 / 245 | 58% | 2.59 | 292 / 502 |
stomach | 98% | 266.17 | 351 / 359 | 59% | 3.96 | 168 / 286 |
lymph node | 0% | 0 | 0 / 0 | 100% | 6.14 | 29 / 29 |
muscle | 100% | 10067.86 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 575.73 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.40 | 1 / 1 |
adipose | 99% | 446.34 | 1191 / 1204 | 0% | 0 | 0 / 0 |
heart | 98% | 620.48 | 844 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 97% | 375.19 | 1299 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 6.88 | 43 / 45 |
peripheral blood | 81% | 297.20 | 748 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 68% | 3.48 | 54 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0042391 | Biological process | regulation of membrane potential |
GO_0051899 | Biological process | membrane depolarization |
GO_0055001 | Biological process | muscle cell development |
GO_0060079 | Biological process | excitatory postsynaptic potential |
GO_0007165 | Biological process | signal transduction |
GO_0034220 | Biological process | monoatomic ion transmembrane transport |
GO_0095500 | Biological process | acetylcholine receptor signaling pathway |
GO_0035095 | Biological process | behavioral response to nicotine |
GO_0006936 | Biological process | muscle contraction |
GO_0007274 | Biological process | neuromuscular synaptic transmission |
GO_0001941 | Biological process | postsynaptic membrane organization |
GO_0007268 | Biological process | chemical synaptic transmission |
GO_0006812 | Biological process | monoatomic cation transport |
GO_0007271 | Biological process | synaptic transmission, cholinergic |
GO_0050877 | Biological process | nervous system process |
GO_0005886 | Cellular component | plasma membrane |
GO_0031594 | Cellular component | neuromuscular junction |
GO_0043005 | Cellular component | neuron projection |
GO_0045202 | Cellular component | synapse |
GO_0099634 | Cellular component | postsynaptic specialization membrane |
GO_0005892 | Cellular component | acetylcholine-gated channel complex |
GO_1904315 | Molecular function | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential |
GO_0015267 | Molecular function | channel activity |
GO_0015464 | Molecular function | acetylcholine receptor activity |
GO_0015276 | Molecular function | ligand-gated monoatomic ion channel activity |
GO_0042166 | Molecular function | acetylcholine binding |
GO_0022848 | Molecular function | acetylcholine-gated monoatomic cation-selective channel activity |
GO_0005515 | Molecular function | protein binding |
Gene name | CHRNB1 |
Protein name | Cholinergic receptor nicotinic beta 1 subunit Acetylcholine receptor subunit beta |
Synonyms | ACHRB CHRNB |
Description | FUNCTION: After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane. . FUNCTION: After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane. . FUNCTION: After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane. . FUNCTION: After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane. . |
Accessions | ENST00000639993.1 [P11230-2] ENST00000575379.1 I3L1T7 P11230 ENST00000536404.6 [P11230-2] ENST00000570557.5 ENST00000576360.1 ENST00000639692.2 [P11230-1] I3L535 I3L3Q9 ENST00000306071.7 [P11230-1] ENST00000572857.5 I3L4N5 |